Home › Trial NCT00262795
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Trial IDNCT00262795
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorGerman CLL Study Group
- Enrollment206
- Start date2003-09
- ConditionsChronic Lymphocytic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.